Abstract

Obesity, a low-grade inflammatory condition, represents a major risk factor for the development of several pathologies including colorectal cancer (CRC). Although the adipose tissue inflammatory state is now recognized as a key player in obesity-associated morbidities, the underlying biological processes are complex and not yet precisely defined. To this end, we analyzed transcriptome profiles of human visceral adipocytes from lean and obese subjects affected or not by CRC by RNA sequencing (n = 6 subjects/category), and validated selected modulated genes by real-time qPCR. We report that obesity and CRC, conditions characterized by the common denominator of inflammation, promote changes in the transcriptional program of adipocytes mostly involving pathways and biological processes linked to extracellular matrix remodeling, and metabolism of pyruvate, lipids and glucose. Interestingly, although the transcriptome of adipocytes shows several alterations that are common to both disorders, some modifications are unique under obesity (e.g., pathways associated with inflammation) and CRC (e.g., TGFβ signaling and extracellular matrix remodeling) and are influenced by the body mass index (e.g., processes related to cell adhesion, angiogenesis, as well as metabolism). Indeed, cancer-induced transcriptional program is deeply affected by obesity, with adipocytes from obese individuals exhibiting a more complex response to the tumor. We also report that in vitro exposure of adipocytes to ω3 and ω6 polyunsaturated fatty acids (PUFA) endowed with either anti- or pro-inflammatory properties, respectively, modulates the expression of genes involved in processes potentially relevant to carcinogenesis, as assessed by real-time qPCR. All together our results suggest that genes involved in pyruvate, glucose and lipid metabolism, fibrosis and inflammation are central in the transcriptional reprogramming of adipocytes occurring in obese and CRC-affected individuals, as well as in their response to PUFA exposure. Moreover, our results indicate that the transcriptional program of adipocytes is strongly influenced by the BMI status in CRC subjects. The dysregulation of these interrelated processes relevant for adipocyte functions may contribute to create more favorable conditions to tumor establishment or favor tumor progression, thus linking obesity and colorectal cancer.

Highlights

  • The increase of obesity afflicting nowadays adults and children worldwide has become a major global health challenge [1]

  • The transcriptome of human adipocytes isolated from visceral adipose tissue (AT) biopsies from control lean and obese (Ob) subjects, affected or not by colorectal cancer (CRC) (NwCRC and obese affected by CRC (ObCRC), respectively), was obtained using RNA sequencing (RNASeq) analysis

  • 869 differentially expressed transcripts (DET) were found in the adipocytes of normal weight affected by CRC (NwCRC) compared to normal weight (Nw) subjects, of which 290 were up-regulated (121 known transcripts), while 579 (321 known transcripts) were down-regulated

Read more

Summary

Introduction

The increase of obesity afflicting nowadays adults and children worldwide has become a major global health challenge [1]. AT is recognized as a key endocrine organ that regulates many metabolic and immune processes and plays a central role in obesity-associated morbidities including colorectal cancer (CRC) [2, 3]. This tissue is endowed with functional pleiotropism relying on its capacity to synthesize and secrete a large array of mediators including cytokines/chemokines, extracellular matrix proteins, hormones, growth and vasoactive factors that influence, either locally or systemically, a variety of physiological and pathological processes [4]. While ω3 PUFA have been described to attenuate inflammation, ω6 PUFA, with a few exceptions, are endowed with pro-inflammatory activity [11, 12]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call